ASXL1 and neoplasm: In this study, U2AF1, DNMT3A, SF3B1, and EZH2 in the secondary tumor group was higher than that in the tumor‐free group, while the mutation rate of ASXL1, TET2, and KMT2D was higher in the tumor‐free group.